Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax...
ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.62 | -18.7311178248 | 3.31 | 3.66 | 2.61 | 1205558 | 2.95818625 | CS |
4 | -2.81 | -51.0909090909 | 5.5 | 9.5599 | 2.61 | 4157655 | 6.3965064 | CS |
12 | 0.57 | 26.8867924528 | 2.12 | 11.18 | 1.6 | 6636453 | 5.50963428 | CS |
26 | 0.75 | 38.6597938144 | 1.94 | 11.18 | 1.0901 | 3535753 | 4.98783173 | CS |
52 | -5.143 | -65.6581131112 | 7.833 | 11.18 | 1.0901 | 1877411 | 5.04766071 | CS |
156 | -65.41 | -96.0499265786 | 68.1 | 84.15 | 1.0901 | 3685620 | 27.499307 | CS |
260 | -42.31 | -94.0222222222 | 45 | 130.65 | 1.0901 | 3161331 | 33.43432827 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.